IPCALAB — Ipca Laboratories Balance Sheet
0.000.00%
- IN₹366.35bn
- IN₹380.70bn
- IN₹89.40bn
- 99
- 10
- 90
- 78
Annual balance sheet for Ipca Laboratories, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
C2021 March 31st | R2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 7,688 | 13,701 | 21,801 | 8,454 | 11,051 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 10,312 | 11,531 | 11,962 | 19,271 | 21,927 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 34,370 | 44,572 | 51,893 | 55,389 | 59,670 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 21,465 | 25,026 | 26,946 | 46,632 | 46,853 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 60,684 | 76,235 | 86,264 | 111,013 | 117,606 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 11,605 | 14,659 | 18,058 | 23,556 | 23,862 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 13,667 | 21,587 | 27,844 | 47,691 | 48,121 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 47,017 | 54,648 | 58,420 | 63,322 | 69,485 |
| Total Liabilities & Shareholders' Equity | 60,684 | 76,235 | 86,264 | 111,013 | 117,606 |
| Total Common Shares Outstanding |